The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 07, 2021

Filed:

Jun. 19, 2017
Applicant:

Hoffmann-la Roche Inc., Little Falls, NJ (US);

Inventors:

Xingchun Han, Shanghai, CN;

Hassan Javanbakht, San Francisco, CA (US);

Henrik Mueller, Basel, CH;

Yongguang Wang, Shanghai, CN;

Song Yang, Shanghai, CN;

Assignee:

HOFFMANN-LA ROCHE INC., Little Falls, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/40 (2006.01); A61K 31/20 (2006.01); A61K 31/4745 (2006.01); A61K 31/7125 (2006.01); C12Q 1/6883 (2018.01); C12N 15/113 (2010.01); C12Q 1/70 (2006.01); A61P 31/14 (2006.01); A61K 31/519 (2006.01); A61P 31/20 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7125 (2013.01); A61K 31/4745 (2013.01); A61K 31/519 (2013.01); A61P 31/14 (2018.01); A61P 31/20 (2018.01); C07K 16/40 (2013.01); C12N 15/113 (2013.01); C12N 15/1137 (2013.01); C12Q 1/6883 (2013.01); C12Q 1/706 (2013.01); C07K 2317/732 (2013.01); C12N 2310/14 (2013.01);
Abstract

The present invention relates to a method for identifying a compound that prevents, ameliorates and/or inhibits a hepatitis B virus (HBV) infection, wherein a compound that (i) reduces the expression and/or activity of PAP associated domain containing 5 (PAPD5) and/or PAP associated domain containing 7 (PAPD7); and/or (ii) binds to PAPD5 and/or PAPD7 and inhibits 5 propagation of HBV; is identified as a compound that prevents, ameliorates and/or inhibits a HBV infection. The invention also provides for an inhibitor of PAPD5 and/or PAPD7 for use in treating and/or preventing a HBV infection; as well as a combined preparation comprising an inhibitor of PAPD5 and an inhibitor of PAPD7 for simultaneous or sequential use in the treatment or prevention of a HBV infection. Also comprised in the present invention is a 10 pharmaceutical composition for use in the treatment and/or prevention of a HBV infection, and a method for monitoring the therapeutic success during the treatment of a HBV infection.


Find Patent Forward Citations

Loading…